AIP
SCPS

Ameritas Investment Partners’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Ameritas Investment Partners’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-450
Closed -$4K – 3306
2021
Q1 		$4K Buy
+450
New +$4.71K ﹤0.01% 3046

Other funds holding SCPS

BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's SCPS Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q2 2021, closing a stake of 450 shares — an estimated $4K sold.

Ameritas Investment Partners first reported a position in SCPS in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 15 funds tracked by Wall St. Rank hold SCPS as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Scopus BioPharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 450 Scopus BioPharma Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Ameritas Investment Partners first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Ameritas Investment Partners's Scopus BioPharma Inc. Common Stock position peaked at $4K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.